Supports capping insulin prices and restricting drug prices

In the 2024 Senate campaign, Hawley introduced Senate bills aimed at lowering prescription drug costs. They would cap insulin prices, bar pharmaceutical companies from selling drugs in the United States at higher prices than in other countries, fine companies that do so, and end prescription drug rebates in federal and private insurance plans.

Context: The passage describes bills he introduced in 2023; it does not establish that they became law. Reported in an October 11, 2024 candidate guide; the exact original statement date is not established.

In their own words

The legislation would cap the price of insulin, bar pharmaceutical companies from selling drugs at higher prices in the U.S.

The source

The Beacon: Missouri Senate candidates' 2024 policy positions

Published: Original date not established; campaign context manually checked
Retrieved: 11/11/2026